| Literature DB >> 24298218 |
Patorn Piromchai1, Sanguansak Thanaviratananich.
Abstract
BACKGROUND: Invasive fungal rhinosinusitis with orbital complications (IFSwOC) is a life-threatening condition. The incidence of mortality has been reported to be up to 80 percent. This study was conducted to determine the risk factors, presentations, clinical, and imaging findings that could help to manage this condition promptly.Entities:
Mesh:
Year: 2013 PMID: 24298218 PMCID: PMC3835877 DOI: 10.1155/2013/453297
Source DB: PubMed Journal: ScientificWorldJournal ISSN: 1537-744X
Demographic data.
| Invasive fungal rhinosinusitis with orbital complications ( | Bacterial rhinosinusitis with orbital complications ( | |
|---|---|---|
| Sex (male : female) | 16 : 19 | 37 : 28 |
| Age (mean ± SD) | 53.80 ± 12.71 | 42.77 ± 22.07 |
| Underlying diseases (%) | ||
| DM | 28 (80) | 14 (21.54) |
| Hematologic diseases | 1 (2.86) | 12 (18.46) |
| Hypertension | 6 (17.14) | 8 (12.31) |
| Renal failure | 2 (5.71) | 8 (12.31) |
| SLE | 0 | 2 (3.08) |
| Orbital complications (%) | ||
| Preseptal cellulitis | 2 (5.71) | 18 (27.69) |
| Orbital cellulitis | 0 | 5 (7.69) |
| Subperiosteal abscess | 14 (40) | 28 (43.08) |
| Orbital abscess | 4 (11.43) | 2 (3.08) |
| Cavernous sinus thrombosis | 15 (42.86) | 12 (18.46) |
Symptoms of invasive fungal rhinosinusitis versus bacterial rhinosinusitis with orbital complications adjusted by severity of orbital complications.
| Invasive fungal rhinosinusitis with orbital complications ( | Bacterial rhinosinusitis with orbital complications ( | Adjusted odds ratio (95% CI) |
| |
|---|---|---|---|---|
| Visual loss | 27 | 27 | 3.12 (1.06–9.22) | 0.03 |
| Diplopia | 12 | 6 | 3.03 (1.08–8.52) | 0.04 |
| Headaches | 23 | 27 | 1.96 (0.67–5.64) | 0.21 |
| Postnasal drips | 2 | 4 | 1.78 (0.18–18.01) | 0.61 |
| Watery rhinorrhea | 8 | 12 | 1.63 (0.41–3.98) | 0.60 |
| Facial pains | 14 | 20 | 1.49 (0.59–3.77) | 0.40 |
| Purulent rhinorrhea | 6 | 9 | 1.20 (0.53–5.00) | 0.39 |
| Coughs | 3 | 7 | 1.10 (0.20–6.07) | 0.91 |
| Stuffiness | 5 | 13 | 0.94 (0.31–2.89) | 0.91 |
| Fevers | 11 | 28 | 0.82 (0.31–2.13) | 0.68 |
| Changes in consciousness | 1 | 4 | 0.40 (0.11–1.41) | 0.15 |
| Toothaches | 2 | 10 | 0.38 (0.07–2.30) | 0.28 |
Clinical signs of invasive fungal rhinosinusitis versus bacterial rhinosinusitis with orbital complications adjusted by severity of orbital complications.
| Invasive fungal rhinosinusitis with orbital complications ( | Bacterial rhinosinusitis with orbital complications ( | Adjusted odds ratio (95% CI) |
| |
|---|---|---|---|---|
| Nasal crust | 14 | 1 | 77.78 (1.95–3095.00) | <0.001 |
| Oculomotor nerve involvement | 34 | 45 | 15.11 (2.16–644.26) | 0.001 |
| Trochlear nerve involvement | 33 | 43 | 5.70 (0.52–62.57) | 0.10 |
| Optic nerve involvement | 22 | 17 | 3.77 (1.50–9.50) | 0.002 |
| Abducens nerve involvement | 33 | 45 | 3.70 (0.40–34.57) | 0.22 |
| Facial swelling | 10 | 8 | 2.37 (0.82–6.80) | 0.10 |
| Trigeminal nerve involvement | 16 | 13 | 1.62 (0.77–3.42) | 0.20 |
| Pus in middle meatus | 16 | 27 | 1.36 (0.57–3.25) | 0.49 |
| Swelling of middle meatus | 28 | 31 | 1.29 (0.55–3.04) | 0.56 |
| Secretion in nasopharynx | 4 | 10 | 0.56 (0.18–1.73) | 0.31 |
| Proptosis | 27 | 45 | 0.53 (0.16–1.79) | 0.30 |
| Periorbital swelling | 20 | 58 | 0.32 (0.12–0.83) | 0.01 |
| Chemosis | 27 | 53 | 0.26 (0.06–1.18) | 0.06 |
Computed tomography findings of invasive fungal rhinosinusitis versus bacterial rhinosinusitis with orbital complications adjusted by severity of orbital complications.
| Invasive fungal rhinosinusitis with orbital complications ( | Bacterial rhinosinusitis with orbital complications ( | Adjusted odds ratio (95% CI) |
| |
|---|---|---|---|---|
| Sinus wall erosion | 10 | 0 | — | — |
| Hyperdensity lesions | 6 | 4 | 4.61 (1.20–17.82) | 0.01 |
| Pan sinus involvement | 8 | 16 | 0.89 (0.31–2.61) | 0.85 |
| Maxillary sinus involvement only | 2 | 13 | 0.43 (0.08–2.38) | 0.32 |
| Sphenoid sinus involvement only | 7 | 5 | 1.42 (0.40–5.06) | 0.60 |
| Two sinus or more involvement | 26 | 44 | 1.41 (0.52–3.90) | 0.49 |